Weight-loss drug ecnoglutide takes aim at knee osteoarthritis pain
Symptom relief
Not yet recruiting
This phase 3 trial tests whether ecnoglutide, a GLP-1 drug similar to semaglutide, can reduce knee pain and body weight in obese adults with knee osteoarthritis. Participants receive either ecnoglutide injections or a placebo for several months. The study measures changes in pain…
Phase: PHASE3 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC